Cargando…

Cost-effectiveness of syringe service programs, medications for opioid use disorder, and combination programs in hepatitis C harm reduction among opioid injection drug users: a public payer perspective using a decision tree

BACKGROUND: The hepatitis C virus (HCV) prevalence rate among injection drug users (IDUs) in North America is 55.2%, with 1.41 million individuals estimated to be HCV-antibody positive. Studies have shown the effectiveness of syringe service programs (SSPs) alone, medications for opioid use disorder...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ijioma, Stephen C, Pontinha, Vasco M, Holdford, David A, Carroll, Norman V
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391166/ https://www.ncbi.nlm.nih.gov/pubmed/33506729 http://dx.doi.org/10.18553/jmcp.2021.27.2.137

Ejemplares similares

Hospital admissions among people who inject opioids following syringe services program implementation
por: Bornstein, K. J., et al.
Publicado: (2020)

Comparison of injecting drug users who obtain syringes from pharmacies and syringe exchange programs in Tallinn, Estonia
por: Vorobjov, Sigrid, et al.
Publicado: (2009)

Ingenuity and resiliency of syringe service programs on the front lines of the opioid overdose and COVID-19 crises
por: Wenger, Lynn D., et al.
Publicado: (2021)

Syringe service program-based telemedicine linkage to opioid use disorder treatment: protocol for the STAMINA randomized control trial
por: Watson, Dennis P., et al.
Publicado: (2021)

Association Between Payer Type and Risk of Persistent Opioid Use After Surgery
por: Srinivasan, Sudharsan, et al.
Publicado: (2023)

The cost-effectiveness of pharmacist-physician collaborative care models vs usual care on time in target systolic blood pressure range in patients with hypertension: a payer perspective
por: Jay, Jessica S, et al.
Publicado: (2021)

Payer Policy Behavior Towards Opioid Pharmacotherapy Treatment in Ohio
por: Molfenter, Todd, et al.
Publicado: (2018)

Economic burden of pediatric prescription opioid poisonings in the United States
por: Patel, Anisha M, et al.
Publicado: (2021)

Harms of prescription opioid use in the United States
por: Imtiaz, Sameer, et al.
Publicado: (2014)

Opioid Consumption after Foot and Ankle Surgery: The Influence of Payer Status
por: Acebo, Joshua, et al.
Publicado: (2019)

Commentary on Vorobjov et al., "Comparison of injection drug users who obtain syringes from pharmacies and syringe exchange programs in Tallinn, Estonia"
por: Werb, Daniel, et al.
Publicado: (2009)

Family burden in injecting versus noninjecting opioid users
por: Nebhinani, Naresh, et al.
Publicado: (2013)

Medication Adherence Trajectories: A Systematic Literature Review
por: Alhazami, Mai, et al.
Publicado: (2020)

Male patients’ preferences for opioid use treatment programs
por: Amini-Rarani, Mostafa, et al.
Publicado: (2023)

Commercial and public payer opioid analgesic prescribing policies: a case study
por: Arfken, Cynthia L., et al.
Publicado: (2021)

Detecting Suicide and Self-Harm Discussions Among Opioid Substance Users on Instagram Using Machine Learning
por: Purushothaman, Vidya, et al.
Publicado: (2021)

Association of opioid fills with centers for disease control and prevention opioid guidelines and payer coverage policies: physician, insurance and geographic factors
por: Togun, Adeniyi T., et al.
Publicado: (2021)

Association of 3 CDC opioid prescription guidelines for chronic pain and 2 payer pharmacy coverage changes on opioid initiation practices
por: Togun, Adeniyi T, et al.
Publicado: (2021)

Expanded syringe exchange programs and reduced HIV infection among new injection drug users in Tallinn, Estonia
por: Uusküla, Anneli, et al.
Publicado: (2011)

Examining Attitudes and Beliefs that Inhibit Pharmacist Implementation of a Statewide Opioid Harm Reduction Program
por: Frenzel, Oliver C., et al.
Publicado: (2020)

Harm Minimisation Drug Policy Implementation Qualities: Their Efficacy with Australian Needle and Syringe Program Providers and People Who Inject Drugs
por: Resiak, Danielle, et al.
Publicado: (2022)

Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs
por: Platt, Lucy, et al.
Publicado: (2017)

Difficulty Accessing Syringes Mediates the Relationship Between Methamphetamine Use and Syringe Sharing Among Young Injection Drug Users
por: Marshall, Brandon D. L., et al.
Publicado: (2011)

Legal space for syringe exchange programs in hot spots of injection drug use-related crime
por: Allen, Sean T., et al.
Publicado: (2016)

The effectiveness of prescription drug monitoring programs at reducing opioid-related harms and consequences: a systematic review
por: Rhodes, Emily, et al.
Publicado: (2019)

Opioid use and opioid use disorder in mono and dual-system users of veteran affairs medical centers
por: Goulet, Joseph, et al.
Publicado: (2023)

Virtual opioid agonist treatment: Alberta’s virtual opioid dependency program and outcomes
por: Day, Nathaniel, et al.
Publicado: (2022)

OralOpioids: Harnessing R Programming and Data Science to Combat Opioid Misuse
por: Banerjee, Ankona, et al.
Publicado: (2023)

Predictors of Chronic Opioid Use: A Population-Level Analysis of North Carolina Cancer Survivors Using Multi-Payer Claims
por: Check, Devon K, et al.
Publicado: (2021)

Characteristics of Patients With Opioid Use Disorder Associated With Performing Overdose Reversals in the Community: An Opioid Treatment Program Analysis
por: Katzman, Joanna G., et al.
Publicado: (2019)

Optimizing naloxone distribution to prevent opioid overdose fatalities: results from piloting the Systems Analysis and Improvement Approach within syringe service programs
por: Patel, Sheila V., et al.
Publicado: (2023)

User-centered design of contingency management for implementation in opioid treatment programs: a qualitative study
por: Becker, Sara J., et al.
Publicado: (2019)

Treatment of Hepatitis C virus among people who inject drugs at a syringe service program during the COVID-19 response: The potential role of telehealth, medications for opioid use disorder and minimal demands on patients
por: Sivakumar, Anishaa, et al.
Publicado: (2022)

Age differences in heroin and prescription opioid abuse among enrolees into opioid treatment programs
por: Cleland, Charles M, et al.
Publicado: (2011)

Prevention, diagnosis, and treatment of opioid use disorder under the supervision of opioid stewardship programs: it’s time to act now
por: Kim, Eun-Ji, et al.
Publicado: (2022)

Injections and infections: understanding syringe service program utilization in a rural state
por: Thakarar, Kinna, et al.
Publicado: (2021)

Opioid Use Stigma: An Examination of Student Attitudes on Harm Reduction Strategies
por: Reynolds, Gemma, et al.
Publicado: (2022)

Safer opioid supply: qualitative program evaluation
por: Haines, Marlene, et al.
Publicado: (2023)

One opioid user saving another: the first study of an opioid overdose-reversal and naloxone distribution program addressing hard-to-reach drug scenes in Denmark
por: Thylstrup, Birgitte, et al.
Publicado: (2019)

Program Adaptations to Provide Harm Reduction Services During the COVID-19 Pandemic: A Qualitative Study of Syringe Services Programs in the U.S.
por: Frost, Madeline C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ruvo2d0tr667n2fi8d848m85ab